--- title: "Lifeloc Technologies (LCTC) stock: news and investor profile" url: "https://aibio.space/companies/lifeloc-technologies/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Lifeloc Technologies, Inc (OTC: LCTC), United States. Listing facts, related biotech companies and news on aibio.space." --- LCTC Lifeloc Technologies, Inc OTC · United States # Lifeloc Technologies (LCTC) news Company Updates · 2026-08-13 ## [Lifeloc reports second-quarter 2026 revenue up 10%](https://aibio.space/news/lifeloc-reports-second-quarter-2026-revenue-up-10-percent/) Net revenue rose to $2.445 million for the quarter ended June 30, 2026, and the company said it is targeting a limited commercial launch of SpinDetect in the first quarter of 2027. ## Latest Lifeloc Technologies news 1. 2026-06-15 Company Updates [Lifeloc completes SpinDetect disk tooling and sets a staged rollout](https://aibio.space/news/lifeloc-completes-spindetect-disk-tooling-sets-staged-rollout/) Lifeloc completed production tooling for its SpinDetect test disks, commissioned a cleanroom, and expects a commercial launch in late 2026 or early 2027. 2. 2026-05-15 Company Updates [Lifeloc reports first quarter 2026 results and SpinDetect milestone](https://aibio.space/news/lifeloc-reports-first-quarter-2026-results-spindetect-milestone/) Net revenue rose 1% to $2.294 million and the quarterly net loss narrowed. The company said production tooling for its SpinDetect drug analyzer is complete and first article disks have been delivered. 3. 2026-05-08 Debt Financing [Lifeloc borrows $500,000 from its Chairman and CFO](https://aibio.space/news/lifeloc-borrows-500-000-chairman-cfo/) Lifeloc Technologies entered into a $500,000 promissory note with Vern Kornelsen, its Chief Financial Officer and Chairman of the Board. The note carries 10.5% interest and is secured by its Wheat Ridge office and most of its assets. ## Lifeloc Technologies at a glance - **Ticker**: LCTC - **Listing**: OTC - **Country**: United States - **Cash, Jun 30, 2026**: $908,208 ### Related companies - [ALCON INC](https://aibio.space/companies/alcon/) NYSE: ALC - [FAMILY OFFICE OF AMERICA, INC.](https://aibio.space/companies/family-office-of-america/) OTC: FOFA - [Quantum Cyber](https://aibio.space/companies/quantum-cyber-n-v/) NASDAQ: QUCY - [Cronos Group](https://aibio.space/companies/cronos/) NASDAQ: CRON - [POSITRON CORP](https://aibio.space/companies/positron/) OTC: POSC - [AXIM BIOTECHNOLOGIES, INC.](https://aibio.space/companies/axim-biotechnologies/) OTC: AXIM - [Apyx Medical](https://aibio.space/companies/apyx-medical/) NASDAQ: APYX - [LEMAITRE VASCULAR INC](https://aibio.space/companies/lemaitre-vascular/) NASDAQ: LMAT ### Also on OTC - [InVitro International](https://aibio.space/companies/invitro-international/) IVRO - [RepliCel Life Sciences](https://aibio.space/companies/replicel-life-sciences/) REPCF - [Sigyn Therapeutics](https://aibio.space/companies/sigyn-therapeutics/) SIGY - [GB Sciences](https://aibio.space/companies/gb-sciences/) GBLX - [Vicapsys Life Sciences](https://aibio.space/companies/vicapsys-life-sciences/) VICP - [Elite Pharmaceuticals](https://aibio.space/companies/elite-pharmaceuticals/) ELTP ## Lifeloc Technologies annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$9.0 million](https://www.sec.gov/Archives/edgar/data/1493137/000107997326000376/) | [$8.5 million](https://www.sec.gov/Archives/edgar/data/1493137/000107997326000376/) | | Research and development | [$2.2 million](https://www.sec.gov/Archives/edgar/data/1493137/000107997326000376/) | [$2.2 million](https://www.sec.gov/Archives/edgar/data/1493137/000107997326000376/) | | Net income (loss) | [-$2.5 million](https://www.sec.gov/Archives/edgar/data/1493137/000107997326000376/) | [-$1.1 million](https://www.sec.gov/Archives/edgar/data/1493137/000107997326000376/) | | Cash from operations | [-$499,319](https://www.sec.gov/Archives/edgar/data/1493137/000107997326000376/) | [-$1.3 million](https://www.sec.gov/Archives/edgar/data/1493137/000107997326000376/) | | Cash and equivalents | [$746,001](https://www.sec.gov/Archives/edgar/data/1493137/000107997326001088/) | [$1.2 million](https://www.sec.gov/Archives/edgar/data/1493137/000107997326001088/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $908,208. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Lifeloc Technologies What is the ticker symbol of Lifeloc Technologies? Lifeloc Technologies, Inc trades under the ticker LCTC on OTC. Where is Lifeloc Technologies listed? Lifeloc Technologies, Inc is listed on OTC. Which country or territory is Lifeloc Technologies listed under? Our directory records Lifeloc Technologies, Inc under United States. Does aibio.space cover Lifeloc Technologies? aibio.space lists Lifeloc Technologies, Inc among 2,820 public biotech companies and publishes its news here as stories appear. What was Lifeloc Technologies's revenue last year? $9.0 million for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is Lifeloc Technologies profitable? Lifeloc Technologies, Inc reported a net loss of $2.5 million for the fiscal year ended Dec 31, 2025, and used $499,319 of cash in operations, per its annual report to the SEC. How much does Lifeloc Technologies spend on research and development? $2.2 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does Lifeloc Technologies have? $908,208 in cash at Jun 30, 2026, per its 10-Q. What is the latest Lifeloc Technologies (LCTC) stock news? Our latest story on Lifeloc Technologies, dated Aug 13, 2026: "Lifeloc reports second-quarter 2026 revenue up 10%". Net revenue rose to $2.445 million for the quarter ended June 30, 2026, and the company said it is targeting a limited commercial launch of SpinDetect in the first quarter of 2027. [Source](https://aibio.space/news/lifeloc-reports-second-quarter-2026-revenue-up-10-percent/). Does Lifeloc Technologies have debt, a term loan or convertible notes? Our latest debt story, dated May 8, 2026: "Lifeloc borrows $500,000 from its Chairman and CFO". Lifeloc Technologies entered into a $500,000 promissory note with Vern Kornelsen, its Chief Financial Officer and Chairman of the Board. The note carries 10.5% interest and is secured by its Wheat Ridge office and most of its assets. [Source](https://aibio.space/news/lifeloc-borrows-500-000-chairman-cfo/). How long will Lifeloc Technologies's cash last? From our story of May 15, 2026: The release does not give a date for beta testing, and it does not state a cash runway figure. [Source](https://aibio.space/news/lifeloc-reports-first-quarter-2026-results-spindetect-milestone/). How can I follow Lifeloc Technologies (LCTC) news? Press Follow on this page to add Lifeloc Technologies to your Following list, or subscribe to the aibio.space newsletter. We have published 4 stories naming Lifeloc Technologies so far, in Company Updates, Debt Financing. ## Investor discussion: Lifeloc Technologies Members talk about Lifeloc Technologies (LCTC). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Lifeloc Technologies, newest first. Each line links the filing it comes from. 1. 2026-06-05 Legal Reported a change of independent auditor. SEC Form 8-K (Items 4.01,5.07,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1493137/000107997326000791/lctc_8k.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:LCTC on TradingView](https://www.tradingview.com/symbols/OTC-LCTC/). ## Listing details Lifeloc Technologies, Inc is a public biotech or pharmaceutical company listed on OTC under the ticker LCTC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Lifeloc Technologies, Inc - **Ticker**: LCTC - **Listing**: OTC - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/lifeloc-technologies/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Lifeloc Technologies (LCTC) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/lifeloc-technologies/